DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Abdel-Rahman O, ElHalawani H, Ahmed H.
Doublet BRAF/MEK inhibition versus single-agent BRAF inhibition in the management of BRAF-mutant advanced melanoma, biological rationale and meta-analysis of published data.
Clin Transl Oncol 2015; Oct 30. [Epub ahead of print]
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.